Repeated Intrathecal Stem Cells Optimize Neuroplasticity and Motor Function in Moderate‐to‐Severe Cerebral Palsy of Rats
Stem Cells International · 2025-01 · 2025 (1)
DOI: 10.1155/sci/4337435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells International, online erschienen am 28.12.2025. Verfasst von Yi Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China, gzhmc.edu.cn. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
Human umbilical cord‐derived mesenchymal stem cells (hUC‐MSCs) ameliorate motor deficits in cerebral palsy (CP), but the effect of injection frequency remains unclear. Moreover, most studies have focused on mild CP models (unilateral carotid artery occlusion [UCAO] model). This study explored the effect and mechanism of hUC‐MSCs in a rat model of moderate‐to‐severe CP (bilateral carotid artery occlusion [BCAO] model). On postnatal Day 4 (P4), Wistar rat pups underwent BCAO induction. Subsequently, they received either a single intrathecal injection of hUC‐MSCs on P21 or repeated injections on P21, P28, P35, and P42. Motor performance was assessed using the rotarod and front‐limb suspension tests, while neuronal regeneration and inflammation were evaluated via biomarkers including neuronal nuclear antigen (NeuN), ionized calcium‐binding adapter molecule‐1 (Iba‐1), glial fibrillary acidic protein (GFAP), myelin basic protein (MBP), and brain‐derived neurotrophic factor (BDNF). P18 model screening confirmed that the BCAO model resulted in more severe brain damage and motor impairment than the UCAO model. After injection of lentivirally transfected hUC‐MSCs, it was found that hUC‐MSCs could nest in the damaged area and survive for at least 3 days. Administration of hUC‐MSCs following BCAO modeling led to notable improvements in both behavioral performance and histological outcomes. Furthermore, repeated injections offered greater therapeutic benefits compared to single injection. It indicated that the efficacy of repeated injections of hUC‐MSCs in the treatment of moderate‐to‐severe CP was superior to that of single injection. Its mechanism was related to the improvement of damaged myelin structure, reduced immunoinflammatory responses, and increased neurotrophic support.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China, gzhmc.edu.cn.
- Department of Sports and Health, Guangzhou Sport University, Guangzhou, Guangdong, China, gipe.edu.cn.
- School of Exercise and Health, Shanghai University of Sport, Shanghai, China, sus.edu.cn.
ORCID-Profile: Yi Xu, Ting-Ting Peng, Shiya Huang, Xiaolin Guo, Jie Luo, Tingting Peng, Liru Liu, Mingshan Han, Ting Gao, Hongmei Tang, Jing Zhang, Lu He, Kaishou Xu
Förderung
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Xu, Y., Peng, T. T., Huang, S., Guo, X., Luo, J., Peng, T., Liu, L., Han, M., Gao, T., Tang, H., Zhang, J., He, L., & Xu, K. (2025). Repeated Intrathecal Stem Cells Optimize Neuroplasticity and Motor Function in Moderate‐to‐Severe Cerebral Palsy of Rats. Stem Cells International, 2025(1). https://doi.org/10.1155/sci/4337435
Vancouver
Xu Y, Peng TT, Huang S, Guo X, Luo J, Peng T, et al. Repeated Intrathecal Stem Cells Optimize Neuroplasticity and Motor Function in Moderate‐to‐Severe Cerebral Palsy of Rats. Stem Cells International. 2025;2025(1). doi:10.1155/sci/4337435
BibTeX
@article{Xu2025,
author = {Xu, Yi and Peng, Ting-Ting and Huang, Shiya and Guo, Xiaolin and Luo, Jie and Peng, Tingting and Liu, Liru and Han, Mingshan and Gao, Ting and Tang, Hongmei and Zhang, Jing and He, Lu and Xu, Kaishou},
title = {Repeated Intrathecal Stem Cells Optimize Neuroplasticity and Motor Function in Moderate‐to‐Severe Cerebral Palsy of Rats},
journal = {Stem Cells International},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/sci/4337435}
}
EUVIMED